NCT02060162View on ClinicalTrials.gov

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

CompletedOBSERVATIONAL
Enrollment

897

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Hepatitis B VirusHIVAntiretroviral TherapyAfricaLiver FibrosisAlcohol Use Disorder
Interventions
OTHER

Standard of care

routine standard of care per Ministry of Health protocol including blood draws and examinations.

Trial Locations (1)

Unknown

Centre for Infectious Disease Research in Zambia, Lusaka

All Listed Sponsors
collaborator

Centre for Infectious Disease Research in Zambia

OTHER

collaborator

University of Bern

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT02060162 - Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa | Biotech Hunter | Biotech Hunter